GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Opthea Ltd (OTCPK:CKDXF) » Definitions » Margin of Safety % (DCF FCF Based)

CKDXF (Opthea) Margin of Safety % (DCF FCF Based) : N/A (As of Apr. 09, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Opthea Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Opthea's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

Competitive Comparison of Opthea's Margin of Safety % (DCF FCF Based)

For the Biotechnology subindustry, Opthea's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Opthea's Margin of Safety % (DCF FCF Based) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Opthea's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Opthea's Margin of Safety % (DCF FCF Based) falls into.


;
;

Opthea Margin of Safety % (DCF FCF Based) Related Terms

Thank you for viewing the detailed overview of Opthea's Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Opthea Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Opthea Ltd (OTCPK:CKDXF) » Definitions » Margin of Safety % (DCF FCF Based)
Comparable Companies
ASX:CU6 ASX:PYC ASX:BOT ASX:CUV ASX:IMM ASX:OCC ASX:IMU ASX:DXB ASX:RAC ASX:PAR VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
OPT:USA UKJ:Germany OPT:Australia
Address
650 Chapel Street, Level 4, Suite 0403, South Yarra, VIC, AUS, 3141
Website
https://www.opthea.com
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.